Target cells are a critical component of immune cell effector assays. Whether investigating TDCC or ADCC, we create engineered target cells uniquely suited for the evaluation of effector function and molecule specificity. But how do we achieve this and what are the principles we follow?
|
October 19, 2022
|
6 min read
Target cells are a critical component of immune cell effector assays. Whether investigating T cell dependent cellular cytotoxicity (TDCC) or antibody dependent cellular cytotoxicity (ADCC), we create engineered target cells uniquely suited for the evaluation of effector function and molecule specificity. But how do we achieve this and what are the principles we follow?
One of the most efficient techniques for the introduction of genetic information into mammalian cells is the use of replication incompetent lentiviruses (LV). There are three primary reasons our molecular biologists recommend LV for engineering;
Our specialist teams have experience in generating genetically engineered cell lines for a variety of purposes. In addition to standard cell line production we have created bespoke engineered cell lines to achieve;
Lentiviruses are RNA viruses that belong to the family Retroviridae and are capable of transducing dividing and non-dividing cells. They are mainly used as viral vectors which have undergone a series of extensive modifications where all pathogenic and replicative properties have been removed. Lentiviruses are widely used to generate stably expressing mammalian cell lines. Most lentiviral vectors used in gene therapy and in vitro applications are derived from the human immunodeficiency virus (HIV).
Join our community of curious minds.
Sign up for our monthly newsletter and receive the latest scientific breakthroughs, industry trends, and expert commentary delivered straight to your inbox.
We specialise in creating cell lines for cell-based functional assessments. Our team are experts at generating a variety of genetically engineered cell lines. Learn about best practices by downloading our cell engineering whitepaper.
Access our whitepaper